| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Oral alkaline phosphatase (Synthetic Biologics) | SYN-020 | Phase 1 Clinical | Massachusetts General Hospital, Theriva Biologics Inc | Celiac Disease; Enteritis; Inflammatory Bowel Diseases; Metabolic Syndrome | Details |